Ruxolitinib salvage therapy is effective for steroid-refractory graft-versus-host disease in children: A single-center experience.

Vedat UygunGülsün KarasuHayriye DaloğluSeda ÖztürkmenSuar Çakı KılıçKoray YalÇinSafiye Suna ÇelenVolkan HazarAkif Yeşilipek

Published in: Pediatric blood & cancer (2020)

Steroid-refractory acute and chronic pediatric GVHD patients treated with ruxolitinib had a high overall response rate, with the additional benefit of steroid sparing.

Keyphrases

liver failure
young adults
drug induced
respiratory failure
stem cells
allogeneic hematopoietic stem cell transplantation
mesenchymal stem cells
aortic dissection
bone marrow
acute respiratory distress syndrome
extracorporeal membrane oxygenation
mechanical ventilation